β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH)
ISO 9 Inquiries
108347-85-9
pharmaceutical grade
98%
shanghai
25kg/Cardboard Drum
Yes
2024-04-22
Dyes,Textile agent,Medical intermediate,API,Pigments,Basic Chemicals
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceNMNH (reduced Nicotinamide Mononucleotide) is a new potent NAD+ precursor. It is a new form of NMN, can increase NAD levels to a much higher extent.NMNH is a fluorescent molecule, in contrast to NMN. The molecular formulae for NMNH is C11H17N2O8P and it is also known as 1-(5-O-phosphono-beta-D-ribofuranosyl) -1,4-dihydropyridine-3-carboxamide Reduced nicotinamide mononucleotide.
β-Nicotinamide mononucleotide, reduced form disodium (β-NMN) is the oxidized form of NAD+ precursor and is a NAD+ enhancer. β-Nicotinamide mononucleotide, reduced form disodium can be reduced to dihydronicotinamide mononucleotide (NMNH). NMNH inhibits glycolysis, TCA cycle, and cell growth.CertificatesBasic Info-
Product Name:
β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH)
Other Name:β-nicotinamide mononucleotide, reduced form, disodium salt(NMNH);NMNH β-nicotinamide mononucleotide, reduced form, disodium salt;NMNH;β-nicotinamide mononucleotide, reduced form, disodium salt;β-Nicotinamide mononucleotide, reduced form;NMNH(β-Nicotinamide mononucleotide Reduced );β-nicoChemicalbooktinamidemononucleotide,reducedform,disodiumsalt;β-Nicotinamide mononucleotide Reduced
CAS No.:108347-85-9
Molecular Formula:C11H18N2NaO8P
InChIKeys:LSKSZICSFLRXJW-RAJFINMANA-N
Molecular Weight:360.23
Color/Form:Light yellow to yellow
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Dyes,Textile agent,Medical intermediate,API,Pigments,Basic Chemicals
-
Location:
Room 507, Dongnan Technology R&D Center, No.438 Jincheng Road, Beigan Street, Xiaoshan District,Hangzhou City,Zhengjiang Province,China
-
Payment Terms:
TT against copy of documents,L/C,100% TT in advance
-
Average lead Time:
20 days
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
51-100
-
Year of Establishment:
2013
-
-
Inquiry History9 Inquiries
Country Product Purchase Quantity Date Posted
India
NMNH(β-Nicotinamide mononucleotide Reduced )
20 KG Oct 31, 2023
United States
NMNH(β-Nicotinamide mononucleotide Reduced )
35 KG Aug 27, 2025
Philippines
a-nmn
1 KG Feb 23, 2026
United States
NMNH
50 G Jun 11, 2024
Switzerland
NMNH
50 G Mar 26, 2024
Philippines
Nmnh
100 G Dec 13, 2023
Ireland
NMNH
1 KG Dec 25, 2023
United States
NMNH
500 G Dec 13, 2023
United States
NMNH(β-Nicotinamide mononucleotide Reduced )
500 G Nov 15, 2023 Post an enquiry for this product
More from this Seller
-
-
-
Upadacitinib
Industrial Grade / 99%
-
-
-
-
Dodecylbenzene
pharmaceutical grade / 98%
-
-
-
-
Linaclotide API
pharmaceutical grade / 98%
-
-
-
-
Diethyl 1,3-acetonedicarboxylate
Industrial Grade / 98%
-






